- 101. Lymphatic Vessel Endothelium
- (UMLS (NCI) C1180786) =Tissue ;
| - 151. Lymphoid Tissue, Mucosa-associated
- [Lymphoid tissue located beneath the mucosal epithelia of those mucosal surfaces that have contact with the external environment, such as the respiratory, digestive, and urinary systems. MALT consists of a collection of predominantly small lymphocytes, fewer larger, transformed lymphocytes, and plasma cells. It protects the body from pathogens that enter via the mucosa. MALT gives rise to a distinctive type of B-cell lymphoma that usually follows an indolent clinical course. ( NCI )] (UMLS (NCI) C0599921) =Tissue ;
|
- 102. lymphedema
- [edema due to obstruction of lymph vessels or disorders of the lymph nodes. ( CSP )] (UMLS (NCI) C0024236) =Disease or Syndrome ;
=adenopathy;
=Elephantiasis;
| - 152. Lymphoid-Restricted Immunoglobulin Octamer Binding Protein NF-A2
- [Encoded by human POU2F2 Gene (POU2 Family), alternative isoforms 1 (478-aa, 51-kD), 2 (466-aa), 3 (462-aa), and 4 (399-aa) of transcription factor OTF-2 contain a DNA binding homeobox domain, bind to octamer motif ATTTGCAT, and regulate Ig gene expression and transcription in several other tissues. OTF-2 also interacts with transcription activators NR3C1, AR, and PGR. Neuronal NOS gene is a target of OTF-2. (from LocusLink, Swiss-Prot, OMIM, and NCI) ( NCI )] (UMLS (NCI) C1442823) Lymphoid-Specific OTF2;
02.îêò;
Octamer Transcription Factor-2;
Octamer-Binding Transcription Factor 2;
OTF-2;
POU Domain, Class 2, Transcription Factor 2;
POU Homeodomain Transcription Factor 2;
POU2F2;
=Amino Acid, Peptide, or Protein; Biologically Active Substance |
- 103. Lymphoblast
- [a morphologically immature lymphocyte, once thought to represent an early stage in lymphocyte development but now known to be an activated lymphocyte that has been transformed in response to antigenic stimulation. ( CSP )] (UMLS (NCI) C0229613) =Cell =hematopoietic stem cell;
lymphocyte | - 153. Lymphoid-Specific OTF 1
- [Encoded by human POU2F1 Gene (POU2 Family), ubiquitous transcription factor OTF-1 contains one homeobox domain, binds to the octamer ATTTGCAT motif, and activates genes for some snRNA, histone H2B, and immunoglobulins. POU domain proteins contain a bipartite DNA-binding domain divided by a flexible linker that enables diverse monomeric configurations on DNA; additional versatility is conferred by dimerization. OTF-1 POU dimers on palindromic OCT factor recognition elements, or PORE, (ATTTGAAATGCAAAT) can recruit transcriptional coactivator OBF1. OTF-1 interacts with transcription activators NR3C1, AR, and PGR. (from LocusLink, Swiss-Prot, and NCI) ( NCI )] (UMLS (NCI) C1442824) NF-A1;
NF-III;
Nuclear Factor III;
01.îêò;
Octamer Transcription Factor-1;
Octamer-Binding Transcription Factor 1;
OTF-1;
POU Domain, Class 2, Transcription Factor 1;
POU2F1 =Amino Acid, Peptide, or Protein; Biologically Active Substance |
- 104. Lymphoblastic Lymphoma
- (UMLS (NCI) C0079748) =Neoplastic Process =histiocytic lymphoma;
Lymphoma, Diffuse;
High Grade Lymphoma;
Lymphoma, T-Cell | - 154. lymphokine
- [soluble mediators of immune responses that are not antibodies or complement components and that are released by sensitized lymphocytes on contact with antigen. ( CSP )] (UMLS (CSP) C0024297) =Amino Acid, Peptide, or Protein; Immunologic Factor =Cytokine;
=costimulator;
Colony-Stimulating Factor 2 Alpha;
B cell activating factor;
B Cell Differentiation Factor I;
LT;
MIF;
OAF;
macrophage activating factor;
IL15;
|
- 105. Lymphochin
- (UMLS (NCI) C1142666) =Organic Chemical; Pharmacologic Substance
| - 155. lymphokine receptor
- [ ] (UMLS (CSP) C0598264) =Amino Acid, Peptide, or Protein; Immunologic Factor; Receptor
|
- 106. LymphoCide
- (UMLS (NCI) C1174750) =Amino Acid, Peptide, or Protein; Pharmacologic Substance; Immunologic Factor
| - 156. Lympholysin
- (UMLS (NCI) C0729025) =Organic Chemical; Pharmacologic Substance; Hazardous or Poisonous Substance
|
- 107. Lymphocin
- (UMLS (NCI) C0878246) =Organic Chemical; Pharmacologic Substance ;
| - 157. lymphoma
- [malignant (clonal) proliferation of B- or T- lymphocytes which involves the lymph nodes, bone marrow and/or extranodal sites; general term for various neoplastic diseases of the lymphoid tissue. ( CSP )] (UMLS (NCI) C0024299) =Neoplastic Process ;
=Lymphoproliferative Disorder;
Neoplasms by Histologic Type;
blood/lymphatic cancer;
=Doenca de Hodgkin;
histiocytic lymphoma;
Lymphoma, Non-Hodgkin;
fowl paralysis;
MF;
Neoplasm of the Thymus;
Lymphoma, Diffuse;
lymph node neoplasm;
Doenca de Hodgkin;
Alpha Heavy Chain Disease;
Lymphoma, Non-Hodgkin;
plasmacytoma;
Reticuloendothelial Hyperplasia;
|
- 108. Lymphocryptovirus
- [A genus of the family HERPESVIRIDAE, subfamily GAMMAHERPESVIRINAE, infecting B-cells in humans and new world primates. The type species human herpesvirus 4 (HERPESVIRUS 4, HUMAN) is better known as the Epstein-Barr virus. ( MSH )] (UMLS (CSP) C0206562) =Virus
| - 158. Lymphoma by Site
- (UMLS (NCI) C1334465) =Neoplastic Process
|
- 109. lymphocyte
- [white blood cells formed in the body's lymphoid tissue. ( CSP )] (UMLS (NCI) C0024264) =Cell ;
=leukocyte;
Body Part =B Cell;
T Cell;
Lymphoblast;
| - 159. Lymphoma by Stage
- (UMLS (NCI) C1272836) =Clinical Attribute
|
- 110. lymphocyte accessory molecule
- [ ] (UMLS (CSP) C0598775) =Amino Acid, Peptide, or Protein; Immunologic Factor; Receptor
| - 160. Lymphoma of Mediastinum
- (UMLS (NCI) C1334665) Lymphoma of the Mediastinum;
Mediastinal Lymphoma;
Mediastinal Malignant Lymphoma;
Primary Mediastinal Lymphoma;
=Neoplastic Process |
- 111. lymphocyte activation
- [Lymphocyte Activation involves stimulation of the production and activity of lymphocytes. Formed in lymphoid tissue, lymphocytes are white blood cells that can generally be classified as either T- or B-cells. T-lymphocytes provide cell-mediated immunity, while B-lymphocytes produce antibodies that provide humoral immunity. Stimulation increases the immune response to invading substances. ( NCI )] (UMLS (CSP) C0024262) =Cell Function ;
| - 161. Lymphoma of Nasal Cavity
- (UMLS (NCI) C1334921) Lymphoma of the Nasal Cavity;
Nasal Cavity Lymphoma;
Primary Nasal Cavity Lymphoma =Neoplastic Process ;
|
- 112. lymphocyte depletion therapy
- [ ] (UMLS (CSP) C1171354) =Therapeutic or Preventive Procedure ;
| - 162. Lymphoma of Orbit
- (UMLS (NCI) C0271333) =Neoplastic Process
|
- 113. lymphocyte differentiation antigen
- [ ] (UMLS (CSP) C0023158) =Organic Chemical; Immunologic Factor
| - 163. Lymphoma of Pancreas
- (UMLS (NCI) C1335307) Lymphoma of the Pancreas;
Pancreatic Lymphoma =Neoplastic Process |
- 114. lymphocyte homing receptor
- [Cell surface glycoproteins on lymphocytes and other leukocytes that mediate adhesion to specialized blood vessels called high endothelial venules. Several different classes of lymphocyte homing receptors have been identified, and they appear to target different surface molecules (addressins) on high endothelial venules in different tissues. The adhesion plays a crucial role in the trafficking of lymphocytes. ( MSH )] (UMLS (CSP) C0080097) =Amino Acid, Peptide, or Protein; Immunologic Factor; Receptor ;
| - 164. Lymphoma of Prostate
- (UMLS (NCI) C1335512) Lymphoma of the Prostate;
Primary Prostate Lymphoma;
Prostate Lymphoma;
=Neoplastic Process |
- 115. Lymphocyte Microcytotoxicity Assay
- [Lymphocyte Microcytotoxicity Assay ( HL7V3.0 )] (UMLS (HL7) C1553180) =Laboratory Procedure =ObservationMethod;
| - 165. Lymphoma of Rectum
- (UMLS (NCI) C1335685) Lymphoma of the Rectum;
Primary Rectal Lymphoma;
Rectal Lymphoma;
=Neoplastic Process ;
|
- 116. lymphocyte product
- [ ] (UMLS (CSP) C0598797) =Amino Acid, Peptide, or Protein; Immunologic Factor
| - 166. Lymphoma of Retina
- (UMLS (NCI) C0339556) =Neoplastic Process
|
- 117. lymphocyte proliferation
- [activated T blasts expressing surface receptors for IL 2 proliferate in response to IL 2 produced by themselves or other T cell subsets; activated B blasts undergo clonal expansion and maturation under the influence of T cell derived lymphokines. ( CSP )] (UMLS (CSP) C0596873) =Cell Function ;
=antigen presentation;
| - 167. Lymphoma of Small Bowel
- (UMLS (NCI) C0278805) =Neoplastic Process
|
- 118. Lymphocyte-Predominant Thymoma
- [A thymic epithelial neoplasm characterized by the presence of expanded areas which resemble the normal thymic cortex. The neoplastic epithelial cells are small and scant and there is a dense T-lymphocytic component present. Areas of medullary differentiation with or without Hassall's corpuscles are also present. It may be associated with myasthenia gravis, pure red cell aplasia, and hypogammaglobulinemia. It has a low grade malignant potential. The majority of cases occur in the anterior mediastinum as Masaoka stage I tumors. A minority of the cases occur as stage II tumors. ( NCI )] (UMLS (NCI) C1266094) Lymphocyte-Rich Thymoma;
Organoid Thymoma;
Predominantly Cortical Thymoma;
Thymoma Type B1 =Neoplastic Process | - 168. Lymphoma of Spinal Cord
- (UMLS (NCI) C1336044) Lymphoma of the Spinal Cord;
Primary Spinal Cord Lymphoma;
Spinal Cord Lymphoma =Neoplastic Process ;
|
- 119. Lymphocytes
- (UMLS (HL7) C1546705) =Intellectual Product =Specimen Source Codes;
| - 169. Lymphoma of Sternum
- (UMLS (NCI) C1336504) Lymphoma of the Sternum;
Primary Sternal Lymphoma;
Sternal Lymphoma =Neoplastic Process |
- 120. Lymphocytes
- (UMLS (HL7) C1550651) =Body Substance =SpecimenEntityType;
| - 170. Lymphoma of Testis
- (UMLS (NCI) C0349644) =Neoplastic Process
|
- 121. Lymphocytes, Tumor-Infiltrating
- [White blood cells that have left the bloodstream and migrated into a tumor. ( NCI )] (UMLS (NCI) C0079722) =Cell =CTL;
| - 171. Lymphoma of the Thymus
- (UMLS (NCI) C1336745) Lymphoma of Thymus;
Primary Thymic Lymphoma;
Thymic Lymphoma;
Thymus Lymphoma;
=Neoplastic Process ;
|
- 122. Lymphocytic and Plasma Cell Neoplasm
- [A neoplasm composed of a lymphocytic cell population which is usually malignant (clonal) by molecular genetic and/or immunophenotypic analysis. Lymphocytic neoplasms include Hodgkin's and Non-Hodgkin's lymphomas, acute and chronic lymphocytic leukemias, and plasma cell neoplasms. - 2003 ( NCI )] (UMLS (NCI) C0598798) =Neoplastic Process ;
| - 172. Lymphoma of the Thyroid
- [A lymphoma primarily involving the thyroid gland. (NCI05) ( NCI )] (UMLS (NCI) C1336753) Lymphoma of the Thyroid Gland;
Lymphoma of Thyroid;
Lymphoma of Thyroid Gland;
Primary Thyroid Gland Lymphoma;
Thyroid Gland Lymphoma;
Thyroid Lymphoma =Neoplastic Process ;
|
- 123. LYMPHOCYTIC CHORIOMENING
- [ ] (UMLS (ICD9CM) C0153014) =Disease or Syndrome
| - 173. Lymphoma of the Tonsil
- (UMLS (NCI) C1336765) Lymphoma of Tonsil;
Primary Tonsillar Lymphoma;
Tonsil Lymphoma;
Tonsillar Lymphoma =Neoplastic Process ;
|
- 124. Lymphocytic Colitis
- [A subtype of MICROSCOPIC COLITIS, characterized by chronic watery DIARRHEA of unknown origin, a normal COLONOSCOPY but abnormal histopathology on BIOPSY. Microscopic examination of biopsy samples taken from the COLON show infiltration of LYMPHOCYTES in the superficial EPITHELIUM and the underlying connective tissue (lamina propria). ( MSH )] (UMLS (NCI) C0400822) =Disease or Syndrome ;
| - 174. Lymphoma of the Trachea
- (UMLS (NCI) C1336773) Lymphoma of Trachea;
Primary Tracheal Lymphoma;
Tracheal Lymphoma;
=Neoplastic Process ;
|
- 125. Lymphocytic Gastritis
- (UMLS (NCI) C1283271) =Disease or Syndrome
| - 175. Lymphoma of the Ureter
- (UMLS (NCI) C1336876) Lymphoma of Ureter;
Primary Ureter Lymphoma;
Ureter Lymphoma;
Ureteral Lymphoma;
=Neoplastic Process |
- 126. Lymphocytic Infiltrate
- (UMLS (NCI) C0333386) =Pathologic Function
| - 176. Lymphoma Stage I
- (UMLS (NCI) C0332424) =Neoplastic Process
|
- 127. LYMPHOCYTOPENIA
- [decrease in the proportion of lymphocytes in the blood. ( CSP )] (UMLS (ICD9CM) C0024312) =Disease or Syndrome =hypoimmunity;
LEUKOCYTOPENIA NOS =T-Lymphocytopenia, Idiopathic CD4-Positive | - 177. Lymphoma Stage II
- (UMLS (NCI) C0332426) =Finding
|
- 128. lymphocytopoiesis
- [development of lymphatic tissue. ( CSP )] (UMLS (CSP) C0597722) =Organ or Tissue Function ;
=Developmental Process, Multicellular;
| - 178. Lymphoma Stage III
- (UMLS (NCI) C0332428) =Finding
|
- 129. lymphocytosis
- [excess of normal lymphocytes in the blood or in any effusion. ( CSP )] (UMLS (CSP) C0024282) =Disease or Syndrome ;
=leukocytosis;
| - 179. Lymphoma Stage IV
- (UMLS (NCI) C0332434) =Finding
|
- 130. Lymphocytosis (symptomatic)
- [ ] (UMLS (ICD9CM) C1719337) LYMPHOCYTOSIS-SYMPTOMATC =Disease or Syndrome
| - 180. LYMPHOMAS NEC ABDOM
- [ ] (UMLS (ICD9CM) C0153852) =Neoplastic Process
|
- 131. Lymphoepithelial Cancer of the Thymus
- [A rare, usually aggressive primary thymic carcinoma, characterized by a syncytial growth of undifferentiated carcinoma cells and the presence of a lymphoplasmacytic infiltrate. More than 40% of cases are associated with Epstein-Barr virus infection. — 2005 ( NCI )] (UMLS (NCI) C0279706) =Neoplastic Process
| - 181. LYMPHOMAS NEC AXILLA
- [ ] (UMLS (ICD9CM) C0153853) =Neoplastic Process
|
- 132. Lymphoepithelial Carcinoma
- [A nonkeratinizing carcinoma which occurs predominantly in the nasopharynx but also in the tonsils and rarely in other anatomic sites. It is characterized by the presence of large malignant cells with vesicular nuclei, prominent nucleoli, syncytial growth pattern, and a lymphoplasmacytic infiltrate. ( NCI )] (UMLS (NCI) C0334254) =Neoplastic Process
| - 182. LYMPHOMAS NEC HEAD
- [ ] (UMLS (ICD9CM) C0153850) =Neoplastic Process
|
- 133. Lymphoepithelial Salivary Gland Carcinoma
- (UMLS (NCI) C1334461) Salivary Gland Lymphoepithelial Carcinoma =Neoplastic Process
| - 183. LYMPHOMAS NEC INGUIN
- [ ] (UMLS (ICD9CM) C0153854) =Neoplastic Process
|
- 134. Lymphoepithelioma of Nasopharynx
- [A nonkeratinizing nasopharyngeal carcinoma characterized by the presence of large cells with vesicular nuclei and prominent nucleoli, a syncytial growth pattern, and a lymphoplasmacytic infiltrate. ( NCI )] (UMLS (NCI) C0279748) =Neoplastic Process
| - 184. LYMPHOMAS NEC MULT
- [ ] (UMLS (ICD9CM) C0728903) Other malignant lymphomas involving lymph nodes of multiple sites;
=Neoplastic Process |
- 135. lymphogranuloma venereum
- [subacute inflammation of the inguinal lymph glands caused by certain immunotypes of Chlamydia trachomatis; a sexually transmitted disease in the United States but is more widespread in developing countries; do not confuse with granuloma venereum, which is caused by Calymmatobacterium granulomatis, for this use ENTEROBACTERIACEAE DISEASE. ( CSP )] (UMLS (CSP) C0024286) =Disease or Syndrome ;
=chlamydia infection;
Disease (VD), venereal | - 185. LYMPHOMAS NEC PELVIC
- [ ] (UMLS (ICD9CM) C0153855) =Neoplastic Process
|
- 136. lymphogranuloma venereum agent
- [ ] (UMLS (CSP) C0598151) =Rickettsia or Chlamydia ;
| - 186. LYMPHOMAS NEC SPLEEN
- [ ] (UMLS (ICD9CM) C0153856) =Neoplastic Process
|
- 137. lymphography
- [Radiographic study of the lymphatic system following injection of dye or contrast medium. ( MSH )] (UMLS (CSP) C0024290) =Diagnostic Procedure ;
| - 187. LYMPHOMAS NEC THORAX
- [ ] (UMLS (ICD9CM) C0153851) =Neoplastic Process
|
- 138. Lymphohistiocytic Variant Anaplastic Large Cell Lymphoma
- (UMLS (NCI) C1334463) =Neoplastic Process
| - 188. Lymphomatoid Papulosis
- [A chronic, recurrent cutaneous disorder characterized by the presence of spontaneously regressing papules. The papules are composed of an atypical lymphocytic infiltrate that contains anaplastic CD30-positive T-cells, which are found in type A and diffuse large cell type (type C) lymphomatoid papulosis. In a small number of cases, of type B, the lymphocytic infiltrate is composed of small, cerebriform-like lymphocytes that are often negative for CD30. The majority of cases follow a benign clinical course, but some cases are clonal and may progress to lymphoma. Treatment options include low dose methotrexate and psoralen/UVA (PUVA). ( NCI )] (UMLS (NCI) C0206182) =Neoplastic Process =Precancerous Condition;
Pityriasis Lichenoides |
- 139. Lymphohistiocytoid Mesothelioma
- (UMLS (NCI) C1334464) =Neoplastic Process
| - 189. Lymphomatous Adult T-Cell Lymphoma/Leukemia
- [An adult T-cell lymphoma/leukemia characterized by generalized lymphadenopathy without peripheral blood involvement. Most patients have advanced disease, however hypercalcemia is not frequently present. — 2004 ( NCI )] (UMLS (NCI) C1334466) =Neoplastic Process
|
- 140. Lymphoid Follicle
- (UMLS (NCI) C0229654) =Body Part, Organ, or Organ Component ;
| - 190. Lymphoplasmacyte-Rich Meningioma
- [A WHO grade I meningioma characterized by extensive chronic inflammatory infiltrates with the meningothelial component in the background. (Adapted from WHO 2000.) - 2004 ( NCI )] (UMLS (NCI) C0431119) =Neoplastic Process ;
|
- 141. Lymphoid Leukemia (in Remission)
- [The abatement of lymphoid leukemia, response to therapy. ( NCI )] (UMLS (NCI) C0686597) =Neoplastic Process
| - 191. Lymphoplasmacytic Infiltrate
- (UMLS (NCI) C1334467) =Finding
|
- 142. Lymphoid leukemia, subacute
- (UMLS (ICD9CM) C0152271) =Neoplastic Process ;
| - 192. Lymphoplasmacytoid Cell
- (UMLS (NCI) C0333825) =Cell
|
- 143. LYMPHOID MAL NEC ABDOM
- [ ] (UMLS (ICD9CM) C0153861) =Neoplastic Process
| - 193. Lymphoplasmacytoid Lymphoma/Immunocytoma Stage I
- [Ann Arbor Classification: Stage I: Involvement of a single lymph node region (I); or localized involvement of a single extralymphatic organ or site in the absence of any lymph node involvement (IE).- 2003 ( NCI )] (UMLS (NCI) C0854814) Stage I Lymphoplasmacytic Lymphoma/Waldenstrom's Macroglobulinemia;
Stage I Lymphoplasmacytoid Lymphoma/Immunocytoma;
Stage I Waldenstrom's Macroglobulinemia;
Waldenstrom's Macroglobulinemia Stage I =Neoplastic Process |
- 144. LYMPHOID MAL NEC AXILLA
- [ ] (UMLS (ICD9CM) C0153862) =Neoplastic Process
| - 194. Lymphoplasmacytoid Lymphoma/Immunocytoma Stage II
- [Ann Arbor Classification: Stage II: Involvement of two or more lymph node regions on the same side of the diaphragm (II); or localized involvement of a single extralymphatic organ or site in association with regional lymph node involvement with or without involvement of other lymph node regions on the same side of the diaphragm (IIE). - 2003 ( NCI )] (UMLS (NCI) C0854815) Stage II Lymphoplasmacytic Lymphoma/Waldenstrom's Macroglobulinemia;
Stage II Lymphoplasmacytoid Lymphoma/Immunocytoma;
Stage II Waldenstrom's Macroglobulinemia;
Waldenstrom's Macroglobulinemia Stage II =Neoplastic Process |
- 145. LYMPHOID MAL NEC HEAD
- [ ] (UMLS (ICD9CM) C0153859) =Neoplastic Process
| - 195. Lymphoplasmacytoid Lymphoma/Immunocytoma Stage III
- [Ann Arbor Classification: Stage III: Involvement of lymph node regions on both sides of the diaphragm (III), which also may be accompanied by extralymphatic extension in association with adjacent lymph node involvement (IIIE) or by involvement of the spleen (IIIS) or both (IIIE,S). - 2003 ( NCI )] (UMLS (NCI) C0854816) Stage III Lymphoplasmacytic Lymphoma/Waldenstrom's Macroglobulinemia;
Stage III Lymphoplasmacytoid Lymphoma/Immunocytoma;
Stage III Waldenstrom's Macroglobulinemia;
Waldenstrom's Macroglobulinemia Stage III;
=Neoplastic Process |
- 146. LYMPHOID MAL NEC INGUIN
- [ ] (UMLS (ICD9CM) C0153863) =Neoplastic Process
| - 196. Lymphoplasmacytoid Lymphoma/Immunocytoma Stage IV
- [Ann Arbor Classification: Stage IV: Diffuse or disseminated involvement of one or more extralymphatic organs, with or without associated lymph node involvement; or isolated extralymphatic organ involvement in the absence of adjacent regional lymph node involvement, but in conjunction with disease in distant site(s); or any involvement of the liver or bone marrow or nodular involvement of the lung(s). - 2003 ( NCI )] (UMLS (NCI) C0854817) Stage IV Lymphoplasmacytic Lymphoma/Waldenstrom's Macroglobulinemia;
Stage IV Lymphoplasmacytoid Lymphoma/Immunocytoma;
Stage IV Waldenstrom's Macroglobulinemia;
Waldenstrom's Macroglobulinemia Stage IV;
=Neoplastic Process |
- 147. LYMPHOID MAL NEC MULT
- [ ] (UMLS (ICD9CM) C0153866) =Neoplastic Process
| - 197. Lymphoproliferative Disorder
- [Diseases in which cells of the lymphatic system grow excessively. These disorders are often treated like cancer. ( NCI )] (UMLS (NCI) C0024314) =Neoplastic Process =Immunoproliferative Disorders;
adenopathy =agammaglobulinemia;
amyloid disease;
AFLH;
granuloma;
HCD;
AILD;
glandular fever;
hairy cell leukemia;
Leukemia, Lymphocytic;
granulocytic leukemia;
Leukemia Plasmacytic;
Lymphangioleiomyoma;
lymphoma;
AIL;
Immunocytoma, Lymphoplasmacytic Type;
fowl paralysis;
Besnier Boeck disease;
Tumor Lysis Syndrome;
|
- 148. LYMPHOID MAL NEC PELVIC
- [ ] (UMLS (ICD9CM) C0153864) =Neoplastic Process
| - 198. Lymphoquin
- (UMLS (NCI) C0878245) =Organic Chemical; Pharmacologic Substance ;
|
- 149. LYMPHOID MAL NEC SPLEEN
- [ ] (UMLS (ICD9CM) C0153865) =Neoplastic Process
| - 199. LYMPHOSARCOMA ABDOM
- [ ] (UMLS (ICD9CM) C0153706) =Neoplastic Process
|
- 150. LYMPHOID MAL NEC THORAX
- [ ] (UMLS (ICD9CM) C0153860) =Neoplastic Process
| - 200. Lymphosarcoma and reticulosarcoma and other specified malignant tumors of lymphatic tissue
- [ ] (UMLS (ICD9CM) C1955727) =Neoplastic Process
|
home
